Hohenberg, Mark
for the TRAILBLAZER-ALZ 2 Investigators
2 papers on CoChatORCID 0000-0003-2696-6068
Most cited papers
- Verified · note
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., et al. (2023) · JAMA
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,932
- Verified
Dementia risk reduction in practice: the knowledge, opinions and perspectives of Australian healthcare providers
Zheng, L., Godbee, K., Steiner, G. Z., Daylight, G., Ee, C., Hill, T. Y., Hohenberg, M. I., Lautenschlager, N. T., McDonald, K., Pond, D., et al. (2021) · Australian Journal of Primary Health
Dementia and Cognitive Impairment ResearchPatient-Provider Communication in Healthcare
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free